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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S233Th2, Th17, Treg) and activation markers. T-cell cytokine secretion (IL-2, IL-
4, IL-6, IL-10, IL-17A, INF-g, TNF) in SF was measured by cytometric bead
array (CBA) analysis.
Results: Analysis of PB did not show any signiﬁcant difference within the
OA patient groups and in comparison to controls. In SM a distinct inﬁl-
tration of CD4+ T-cells was present in all three OA groups, which signiﬁ-
cantly increasedwith OA stage (p<0.05). Further, CD4+ T-cell subsets in SM
and PB samples were analysed. Whereas in PB only a small proportion of
CD4+ T-cells were activated and stained positive for the speciﬁc subsets,
the majority of SM T-cells were differentiated into the T-cell subsets and
this increasedwith OA stage (Figure 1). The highest increase wasmeasured
for the inﬂammatory T cell subsets Th1 and Th17, which signiﬁcantly
altered the Th1/Th2 and Th17/Treg balance. Further analysis of activation
markers displayed an activated phenotype of CD4+ T-cells in the SM
(CD69+, CD45RO+, CD45RA-, CD62L-) but not in PB. CBA analysis
conﬁrmed a signiﬁcant increase of all T-cell cytokines in the SF of OA
groups 2 and 3 when compared to group 1 (p<0.05). Between group 2 and
3, pro-inﬂammatory Th1 and Th17 cytokines (TNF and IL-17) were further
increased and anti-inﬂammatory Th2 and Treg cytokines (IL-4, IL-10)
decreased in group 3. IL-2, IL-6 and INF-g were slightly higher in group 2.
Conclusions: In contrast to SM, no differences were observed between the
PB samples of OA patients and controls, showing that the relevant role of
inﬂammatory cells in OA remains a local process. The inﬁltration of OA
synoviumwith inﬂammatory cells is not solely a phenomenon of late stage
OA. In fact, CD4+ T-cells are already present and activated in the affected
joints of early OA stages. T-cell inﬁltration and polarisation correlates with
OA disease stages and shifts the Th1/Th2 and Th17/Treg balance towards
an inﬂammatory T-cell phenotype. Thus, onset and progression of OA is
accompanied by an increasing inﬂux of CD4+ T-cells into the SM, their
activation, cytokine production and polarisation. These results underline
the relevance of T-cells in the inﬂammatory process of OA, not only in late-
stage disease but also in early OA stages. In “classical” inﬂammatory joint
diseases such as rheumatoid arthritis we know that T-cell derived
inﬂammation contributes to cartilage degeneration and joint destruction.
The role of these cells in OA needs to be further studied. Nevertheless our
current results suggest that T-cell activation and polarisation may play
a role in both the initiation and progression of OA, and as such provide
a potential therapeutic target.
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OSTEOARTHRITIS-ASSOCIATED BASIC CALCIUM PHOSPHATE CRYSTALS
INDUCE IL-1b, IL-18 AND S100A8 PRODUCTION IN A TYROSINE
KINASE DEPENDENT MANNER.
E. Mills 1, G. McCarthy 2, K. Mills 1, A. Dunne 1. 1 Trinity Coll. Dublin, Dublin,
Ireland; 2Mater Misericordiae Univ. Hosp., Dublin, Ireland
Purpose: Synovial ﬂuid basic calcium phosphate (BCP) crystal deposition
is a marker of severe joint degeneration in osteoarthritis (OA). BCP crystals
are found in the majority of OA joints, where they promote pro-inﬂam-
matory cytokine production and matrix metalloprotease (MMP)expression, suggesting a pathogenic role for these crystals in driving
disease progression. At the molecular level, BCP crystals were shown to
activate synovial ﬁbroblasts and macrophages through a variety of sig-
nalling pathways, including protein kinase C (PKC), ERK1/2, MAP kinase
and NFkB, leading to the induction of cytokines such as TNFa and IL-6.
More recently it has been demonstrated that BCP crystals drive IL-1b and
IL-18 production following activation of the NOD-like receptor, NLRP3. This
event requires two signals, the ﬁrst leading to the production of pro-IL-1b/
18 and the second leading to inﬂammasome complex assembly and
cleavage of the immature cytokines to their biologically active forms. In
this study we sought 1) to determinewhether cell membrane activation by
BCP crystals leads in turn to the activation of the membrane proximal
kinases, Syk and PI3 kinase and 2) to further characterise events down-
stream of Syk activation in order to identify novel molecular targets for the
treatment of BCP related arthropathies.
Methods: Murine dendritic cells and macrophages were stimulated with
BCP crystals, with or without priming with a Toll-like receptor (TLR)
agonist and IL-1b and IL-18 production was quantiﬁed by enzyme linked
immunosorbent assay (ELISA). A role for Syk and PI3 kinase was deter-
mined with the use of the inhibitors, piceatannol and LY294002, respec-
tively. Activation of the kinases was conﬁrmed by western blotting using
phospho-speciﬁc antibodies to Syk and PI3 kinase following treatment of
cells with the crystals over a 30 minute time course. Finally, activation of
the downstream kinase, ERK, and production of the damage associated
molecule, S100A8, was assessed in the presence of piceatannol in order to
determine if these events are associated with BCP dependent Syk
activation.
Results: Physiological concentrations of BCP crystals (50mg/ml) induced
robust IL-1b and IL-18 production in a Syk and PI3 kinase dependent
manner. Activation of the kinases was apparent after approximately
5 minutes treatment with the crystals while pre-incubation with the
inhibitors piceatannol and Ly294002 led to a signiﬁcant reduction in
cytokine levels (>80%). Phosphorylation of the downstream kinase, ERK,
was also prevented following treatment with the Syk inhibitor, picea-
tannol, thus identifying Syk activation as a proximal event in BCP induced
pro-inﬂammatory cytokine production. Finally, we demonstrate that
treatment of cells with BCP crystals leads directly to the induction and
release of the danger-associated molecule, S100A8 and this is also
dependent on activation of Syk.
Conclusions: Based on these studies we propose that membrane acti-
vation by BCP crystals leads directly to the activation of Syk and its
interacting partner, PI3 kinase. Inhibition of these kinases signiﬁcantly
abrogates both IL-1 and IL-18 production as well as activation of the
downstream kinase, ERK. We have also demonstrated that production of
the damage associated molecule, S100A8 is dependent on Syk activation.
Given that S100A8 is considered a TLR 4 ligand, we propose a model
whereby BCP crystals drive the production of S100A8 which in turn leads
to the expression of pro-IL-1b and pro-IL-18 (Signal 1). In dendritic cells/
macrophages, BCP crystals can also induce the activation of the NLRP3
inﬂammasome (Signal 2) leading to the production of the mature forms
of these cytokines. These events are dependent on tyrosine phosphory-
lation and we identify Syk and molecules activated downstream of
this kinase as a potential targets for the treatment of BCP related path-
ologies.
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ALARMINS S100A8 AND S100A9 STIMULATE PRODUCTION OF PRO-
INFLAMMATORY CYTOKINES IN M2 MACROPHAGES WITHOUT
CHANGING THEIR M2 MEMBRANE PHENOTYPE
R.F. Schelbergen 1, A.B. Blom1, W. de Munter 1, T. Vogl 2, J. Roth 2, W.B. van
den Berg 1, P.L. van Lent 1. 1Radboud Univ. Nijmegen Med. Ctr., Nijmegen,
Netherlands; 2 Inst. of Immunology, Munster, Germany
Purpose: Synovial activation, which plays an important role in a subgroup
of osteoarthritis (OA) patients, is regulated by M1/M2 macrophage
subpopulations: pro-inﬂammatory M1-macrophages and regulatory M2-
macrophages. Alarmins S100A8 and S100A9 are found in high concen-
trations in synovial ﬂuid of OA patients and are correlated to inﬂammation
and cartilage destruction. In the current study we investigated the
production of S100A8 and/or S100A9 by M1- and M2-macrophages and
MyD88 and TLR-2/4 deﬁciency offer moderate protection against OA
Avg. Chambers Scores
+/- SEM (OA knees)
KO WT p-values KO
vs. WT
MyD88 Lateral Compartment 2.0 +/- 0.14 2.6 +/- 0.10 p < 0.0001
MyD88 Medial Compartment 6.5 +/- 0.27 8.1 +/- 0.26 p < 0.0001
TLR-2/4 Lateral Compartment 1.1 +/- 0.10 2.1 +/- 0.11 p ¼ 0.0952
TLR-2/4 Medial Compartment 3.5 +/- 0.18 4.1 +/- 0.18 p ¼ 0.028
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them a more pro-inﬂammatory character.
Methods: Monocytes were isolated from blood of healthy volunteers by
isolating peripheral blood mononuclear cells (PBMCs) using a Ficoll-
gradient followed by isolating CD14+ monocytes using magnetic-activated
cell sorting (MACSTM). CD14+ monocytes were differentiated into M1- or
M2-macrophages by 6 day stimulation with either GM-CSF or M-CSF,
respectively. mRNA levels of S100A8 and S100A9 in M1 and M2 macro-
phages were measured with RT-qPCR. Intracellular protein productionwas
determined using FACS analysis and S100A8/A9 secretion was measured
using an ELISA. M1 and M2 macrophages were stimulated with human
recombinant S100A8 and S100A9. M1 and M2 markers (IL-1beta, TNFal-
pha, IL-6 and CD163, CD206 respectively) were measured using RT-qPCR,
FACS and/or Luminex.
Results: S100A8 and S100A9 had a signiﬁcantly higher mRNA expression
(65- and 2.5-fold respectively, n¼10) in human monocyte derived M1-
macrophages compared to M2. Also, the levels of intracellular S100A8 and
S100A9 were higher in M1 than in M2 macrophages (4.3-fold and 6.6-fold
higher respectively, n¼6). M1 macrophages secreted higher levels of
S100A8/A9 heterodimer as compared to M2 macrophages (102.8 ng/ml vs
55.5 ng/ml respectively, n¼10).
Stimulation of human monocyte derived M2-macrophages for 24 hours
with S100A8 and S100A9 showed a marked upregulation of several pro-
inﬂammatory markers: IL-1beta expression was increased by S100A8 and
S100A9 on mRNA level (33- and 16-fold, n¼10). At the protein level IL-6
and TNFalpha were strongly upregulated by S100A8 71- and 146-fold and
by S100A9 93- and 121-fold, respectively (n¼6).
Interestingly however, S100A8 or S100A9 stimulation did not alter the
level of M2membranemarkers CD163 and CD206, both at mRNA as well as
protein level.
Conclusions: Stimulation of M2 macrophages with S100A8 and S100A9,
produced in high amounts by M1- macrophages, upregulates pro-
inﬂammatory cytokines IL-1beta, IL-6 and TNF-alpha while M2 membrane
markers CD163 and CD206 remain unchanged.
S100A8 and S100A9 production during OA could therefore contribute to
synovial activation by stimulating the M2 macrophage towards a more
pro-inﬂammatory phenotype.459
MYD88-DEPENDENT TLR-2/4 SIGNALING IN OSTEOARTHRITIS:
PROTECTIVE OR NOT?
M. Husa 1, X. Zhao 2, H. Yao 2, R. June 3, R. Terkeltaub 2, R. Liu-
Bryan 2. 1UCSD, La Jolla, CA, USA; 2 San Diego VA, La Jolla, CA, USA;
3Montana State, Bozeman, MT, USA
Purpose: Toll-like receptor 2 (TLR-2)/TLR-4-mediated innate immunity
modulates tissue remodeling and repair responses to endogenous ligands
released during chronic, low-grade inﬂammation in osteoarthritis (OA).
Furthermore, stimulation of macrophages with TLR ligands has been
shown to induce superoxide dismutase-2 (SOD2), indicating a role of
innate immunity in maintenance of redox homeostasis. Our lab has
previously demonstrated impaired catabolic responses with MyD88 deﬁ-
ciency and TLR-2/4 combined deﬁciency in chondrocytes in vitro, although
the direct roles of these proteins in in vivo OA pathogenesis remain
unclear. Thus, we sought to determine if TLR-2/4 combined deﬁciency or
MyD88 deﬁciency protects mice from OA induction via medial meniscec-
tomy and whether chondrocytes deﬁcient in MyD88 or TLR-2/4 demon-
strate deﬁciencies in redox mediators.
Methods: MyD88 knockout (MyD88 KO) and TLR-2/TLR-4 double
knockout (TLR-2/4 DKO) animals underwent survival medial meniscec-
tomy surgery at twomonths of age, and were euthanized 8wks after. Their
knee joints were isolated, paraﬁnized, and sectioned, and OAwas analyzed
histologically via safranin-O staining relative to wildtype (WT) controls via
the Chambers scoring system (MyD88: n ¼ 5KO, 5WT. TLR-2/4: n ¼ 9KO,
6WT; Mann-Whitney U Test with two tailed p-values). Expression of
antioxidants SOD2, catalase and thioredoxinwas assessed via western blot
in mature chondrocytes isolated from mouse femoral head cartilage, and
via immunohistochemistry on mouse knee sections from WT and MyD88
or TLR-2/4 deﬁcient animals.Results: Given the known decreases in catabolic responses in vitro with
MyD88 or combined TLR-2/4 deﬁciency, we expected a signiﬁcant
protection from OA development in these mice relative to WT controls.
However, both MyD88 KO and TLR-2/4 DKO animals demonstrated only
a mild to moderate protection against OA (Table). More intriguing, anti-
oxidant protein expression of SOD2, catalase and thioredoxin were all
signiﬁcantly decreased in unstimulated MyD88 KO and TLR-2/4 DKO
chondrocytes and mouse knee sections, relative to WT controls.
Conclusions: To our knowledge, this is the ﬁrst report of a loss of redox
mediators in chondrocytes with innate immune deﬁciency, and suggests
a previously unknown role of innate immunity in maintaining redox
homeostasis in chondrocytes. A loss of redox homeostasis may explain the
lack of a strong protective response against OA induction in mice deﬁcient
in MyD88 or in TLR-2 and TLR-4. Taken together, these data suggest an
interesting dichotomy for the role of innate immunity in OA pathogenesis.
Although TLR-2/4 and MyD88 signal endogenous ligand-induced catabolic
responses and promote chronic low-level inﬂammation in cartilage
chondrocytes, they also seem necessary for maintaining chondrocyte
redox homeostasis. We believe this data offers new and signiﬁcant insight
into OA pathogenesis and signaling of chronic inﬂammatory responses in
chondrocytes.460
MEDIATORS OF THE INFLAMMATORY RESPONSE TO JOINT
REPLACEMENT DEVICES
N. Cobelli, J. Hardin, L. Santambrogio. Albert Einstein Coll., New York, NY,
USA
Purpose: Several inﬂammatory, autoimmune and infective conditions
cause the destruction of the weight bearing surfaces of major joints
causing arthritis. Over one million people in the United States each year
undergo a total joint arthroplasty, which is the prosthetic replacement of
these, destroyed native bearing surfaces. A commonly utilized bearing
surface material is ultra high molecular weight polyethylene (UHMWPE).
Over time different size particles of wear debris are generated from the
UHMWPE implant. These wear debris are responsible for the initiation of
an aseptic inﬂammatory response known as osteolysis. The purpose of this
study is the analysis of the innate immune mechanism utilized by
macrophages, dendritic cells and osteoclasts in recognition of UHMWPE
wear debris.
Methods: UHMWPE wear debris and polymers were characterized by
transmission electron microscopy, mass spectrometry and Fourier
transform infrared spectroscopy. Osteoclasts, macrophages and dendritic
cells activation through the TLR1 and TLR2 signaling pathways was
investigated using gene chip analysis, ko mice and in vitro UHMWPE
binding to recombinant TLR2 molecules. The Nalp3 inﬂammasome
assembly was investigated using Nalp3 ko mice, IL-1 and IL-18 ELISA
assays
Results: We identiﬁed that the process of “in vivo” UHMWPE breakdown
generates short alkane polymers in addition to the previously reported
nanometers and micrometers size particles; the majority of these poly-
mers presented side chain modiﬁcations consisting of aldehyde, ketonic
and hydroxyl groups. Alkane side chains oxidation greatly enhanced their
ability to activate dendritic cells as compared to the general inertness of
the non-oxidized polymers. We also determined that a mixture of oxidized
alkane polymers triggered a pro-inﬂammatory response upon binding to
TLR2 homodimers and TLR1/2 heterodimers. This is the ﬁrst report of
a synthetic polymer engaging a TLR on immune cells. Additionally we
identiﬁed the Nalp3 inﬂammasome assembly, following phagocytosis of
